OUR SERVICES

CRISPR/Cas9 and Cas9 Variants

As an early adopter licensing CRISPR/Cas9 for cells and rodents in 2014, Applied StemCell (ASC) has extensive, hands-on experience utilizing and refining this technology in the lab. Today, advanced Cas9 variants – including CRISPRi and CRISPRa – further expand these capabilities, driving progress in promoter studies, cancer research, and beyond.

How Advanced Cas9 Variants Elevate Your Research:

  • Higher Knock-in Efficiency: Fusion proteins like Cas9-POLD3 and Cas9-CtIP stimulate Homology-Directed Repair (HDR) for faster, more effective integration.

  • Fewer Off-Target Effects: Promoting HDR minimizes unspecific Non-Homologous End Joining (NHEJ), reducing random repairs and off-target edits.

  • Precise Expression Control: Catalytically inactive Cas9 fused to repressors (CRISPRi) or activators (CRISPRa) allows targeted gene silencing or activation without altering the DNA sequence.

Leveraging ASC’s extensive engineering experience – with more than 1,800 unique engineered models delivered and a project success rate above 98% – we are happy to discuss the ideal Cas9 strategy tailored to your specific project. Contact us today!

How does CRISPR/Cas9 work?

Cas9 is a site-specific nuclease that uses a guide RNA to target and cut precise DNA sequences in the genome.

  • The Guide RNA System: In bacteria, Cas9 relies on two separate RNAs: a crRNA, which targets the nuclease to a specific sequence, and a tracrRNA, which binds to the crRNA to activate the Cas9 nuclease. For lab efficiency, these two molecules are combined into a single guide RNA (gRNA or sgRNA).
  • DNA Repair & Editing: Cas9 creates double-strand DNA breaks (DSBs) that cells repair through one of two main pathways:
    • NHEJ (Knock-outs) introduces small insertions or deletions (indels) to disrupt gene function.
    • HDR (Knock-ins) uses a donor plasmid to achieve precise gene insertion or specific point mutations.

Ready to start your project?

Is CRISPR/Cas9 the Right Tool for Your Project?

CRISPR/Cas9 is great forCRISPR/Cas9 is challenging for
Introduction and correction of point mutations
Gene knock-outs via frameshifts, indels and point mutationsPrecise single-copy knock-in
Small knock-ins (less than 5 kb)Large knock-ins > 5 kb – low efficiency
Dividing cellsNon-dividing cells – relies on homologous recombination
Academic and exploratory useCommercial development due to complex IP landscape

Tell us your

  • target gene,
  • host cell type, and
  • payload size

to get a tailored recommendation and competitive quote for your project.